When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BLCM - Bellicum Pharmaceuticals EPS beats by $2.04
Bellicum Pharmaceuticals Inc.
Bellicum Pharmaceuticals (BLCM): Q4 GAAP EPS of $0.98 beats by $2.04.Revenue of $0.5M (-90.3% Y/Y).Cash and cash equivalents and restricted cash totaling $37.0 million as of December 31, 2020, compared to $93.8 million as of December 31, 2019.“We are excited to have resumed our trial of BPX-601 with a focus on prostate cancer and initiated the BPX-603 trial in HER2+ solid tumors, and we look forward to providing updates on both programs as the year progresses.” said Rick Fair, President and CEO.Press Release